![Logo for Anavex Life Sciences Corp](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-icons%2F9876f-2022-09-28-11-44-04.png&w=256&q=100)
Anavex Life Sciences Investor Relations Material
Latest events
![Logo for Anavex Life Sciences Corp](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-icons%2F9876f-2022-09-28-11-44-04.png&w=128&q=100)
Q3 2024
Anavex Life Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Anavex Life Sciences Corp
Access all reports
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. The company's lead drug candidate is 2-73 that has completed phase II clinical trial for the treatment of Alzheimer's disease. Its programs also includes ANAVEX 3-71, which is in pre-clinical testing for the treatment of amyotrophic lateral sclerosis disease; and ANAVEX 1-41, a pre-clinical stage small molecule compound for the treatment of epilepsy.
Key slides for Anavex Life Sciences Corp
![Anavex Investment Hi](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fanavex-life-sciences-corp-investor-presentation-8a4a9ca978caca24%2F5.png&w=3840&q=75)
![Logo for Anavex Life Sciences Corp](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-icons%2F9876f-2022-09-28-11-44-04.png&w=128&q=100)
Investor Presentation
Anavex Life Sciences Corp
![Treating Alzheimer's](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fanavex-life-sciences-corp-hc-wainwright-5th-annual-neuro-perspectives-virtual-conference-7a61065efb0226c4%2F17.png&w=3840&q=75)
![Logo for Anavex Life Sciences Corp](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-icons%2F9876f-2022-09-28-11-44-04.png&w=128&q=100)
H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
Anavex Life Sciences Corp
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2Fbbbaafadba%2Fpontis-dackmo_strong-opinions-loosely-held.png&w=3840&q=75)
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F7455f6afd1%2Fnovo-nordisk_the-danish-pharmaceutical-titan.png&w=3840&q=75)
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F5533bee49f%2Fthe-toyota-way.png&w=3840&q=75)
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
AVXL
Country
🇺🇸 United States